HSV-1 IgM and IgG Test Kits
HSV-1 IgG test and HSV-1 IgM test kits are used in the diagnosis of Herpes Simplex Virus (Type 1) infection.
Atlas Link Technology Co. Ltd is supplying two series of Cytomegalovirus test kits according to the testing methods, namely one-step lateral flow HSV-1 rapid test kits, and HSV-1 Dot Filtration Assay kits. Both can be divided into two types depending on the isotypes of the antibody tested:CMV IgM test kits and CMV IgG test kits.
All the CMV rapid assay kits are based on the principle of Gold Immuno-chromatography Assay (GICA), using the antibody-antigen reaction to detect HSV-1 IgM and IgG antibody isotypes in human serum or plasma specimen respectively, and are used in the diagnosis of Herpes Simplex Type 1 virus infection. These rapid test kits are used as screening test, any positive testing result with these rapid HSV-1 antibody test, more accurate test method is recommended before any clinical conclusion is made.
Why HSV-1 Test Matter
HSV-1 is the cause of most orofacial herpes and HSV encephalitis. The detection of HSV-1 IgM antibody enables effective diagnosis of acute or recent HSV-1 infection. HSV-1 serum testing is particularly useful for the follow-up of pregnant women, who were not previously exposed to HSV-1 and consequently are not protected against the virus. In addition, determination of specific IgM antibody in the newborn is useful for the diagnosis of congenital HSV-1 infection.
The presence of HSV-1 IgG antibody in serum is an indication of previous exposure. A significant increase in HSV IgG is an indication of reactivation, current or recent infection.
Spread of HSV-1
HSV1 primarily infects mouth, throat, face, eye, and central nervous system. The HSV1 are ubiquitous and contagious. They can spread when an infected person is shedding the virus. HSV-1 is usually acquired orally during childhood, but may also be sexually transmitted. Once infected, currently there is no technology to clear the HSV-1 from the body. After several years, some patients will become perpetually asymptomatic.
The risk of transmission from mother to baby is the highest, especially if the mother becomes infected at around the delivery time (30% to 60%), because in these cases there is no sufficient time for the maternal body to secret and transfer antibodies before the delivery. But the risk falls to 3% if it is a recurrent infection, and is less than 1% if there are no visible lesions.